Cécile Fournel-Federico

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

Xavier Pivot, Gilles Romieu, Marc Debled et al. · The Lancet · 2019 · 125 citations

Breast Oncology, Oncology, Early Breast Cancer +6

Vectorized gene therapy of liver tumors: proof-of-concept of TG4023 (MVA-FCU1) in combination with flucytosine

F. Husseini, Jean‐Pierre Delord, Cécile Fournel-Federico et al. · Annals of Oncology · 2016 · 30 citations · Full text

Tumor Biology, Hepatology, Novel Therapy +8

Treatment of Metastatic Breast Cancer

Bénédicte Poncet, Cyrille Colin, Thomas Bachelot et al. · American Journal of Clinical Oncology · 2009 · 29 citations

Depression assessment by oncologists and palliative care physicians

Wadih Rhondali, Élise Perceau, P. Saltel et al. · Palliative & Supportive Care · 2012 · 15 citations

Open-label uncontrolled pilot study to evaluate complementary therapy with Ruta graveolens 9c in patients with advanced cancer

Gilles Freyer, Benoît You, Stéphanie Villet et al. · Homeopathy · 2014 · 15 citations · Full text